CN116133673A - 用于修复黏膜损伤或皮肤创伤的多肽及其应用 - Google Patents

用于修复黏膜损伤或皮肤创伤的多肽及其应用 Download PDF

Info

Publication number
CN116133673A
CN116133673A CN202180044414.2A CN202180044414A CN116133673A CN 116133673 A CN116133673 A CN 116133673A CN 202180044414 A CN202180044414 A CN 202180044414A CN 116133673 A CN116133673 A CN 116133673A
Authority
CN
China
Prior art keywords
pro
val
ala
compound
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180044414.2A
Other languages
English (en)
Inventor
耿福能
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Gooddoctor Panxi Pharmaceutical Co ltd
Original Assignee
Sichuan Gooddoctor Panxi Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Gooddoctor Panxi Pharmaceutical Co ltd filed Critical Sichuan Gooddoctor Panxi Pharmaceutical Co ltd
Publication of CN116133673A publication Critical patent/CN116133673A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

一种用于修复黏膜损伤或皮肤创伤的新型多肽及其应用，所述多肽与已知多肽无同源性，而且能够在体内和体外均稳定存在，具有调控干细胞增殖和分化修复黏膜损伤或皮肤创伤的效果；以及涉及所述新型多肽通过调控干细胞增殖和分化修复黏膜损伤或皮肤创伤的用途，以及用于预防、减轻或治疗胃肠疾病的用途。

Description

PCT国内申请，说明书已公开。

Claims (24)

  1. PCT国内申请，权利要求书已公开。
CN202180044414.2A 2020-07-01 2021-07-01 用于修复黏膜损伤或皮肤创伤的多肽及其应用 Pending CN116133673A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010619687 2020-07-01
CN2020106196872 2020-07-01
PCT/CN2021/103943 WO2022002186A1 (zh) 2020-07-01 2021-07-01 用于修复黏膜损伤或皮肤创伤的多肽及其应用

Publications (1)

Publication Number Publication Date
CN116133673A true CN116133673A (zh) 2023-05-16

Family

ID=79010423

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202180044414.2A Pending CN116133673A (zh) 2020-07-01 2021-07-01 用于修复黏膜损伤或皮肤创伤的多肽及其应用
CN202110747197.5A Active CN113880915B (zh) 2020-07-01 2021-07-01 用于修复黏膜损伤或皮肤创伤的多肽及其应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202110747197.5A Active CN113880915B (zh) 2020-07-01 2021-07-01 用于修复黏膜损伤或皮肤创伤的多肽及其应用

Country Status (10)

Country Link
US (1) US20230295233A1 (zh)
EP (1) EP4177259A1 (zh)
JP (1) JP2023531282A (zh)
KR (1) KR20230031898A (zh)
CN (2) CN116133673A (zh)
AU (1) AU2021302188A1 (zh)
CA (1) CA3184710A1 (zh)
IL (1) IL299498A (zh)
TW (1) TW202202515A (zh)
WO (1) WO2022002186A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117045534A (zh) * 2023-10-12 2023-11-14 深圳市维琪科技股份有限公司 六肽的新用途

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202207967A (zh) * 2020-08-26 2022-03-01 大陸商四川好醫生攀西藥業有限責任公司 用於修復皮膚創傷或黏膜損傷的多肽及其應用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214795B1 (en) * 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
US20060293228A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Therapeutic compositions and methods using transforming growth factor-beta mimics
CN108503690B (zh) * 2017-02-28 2020-07-03 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
CN107973838B (zh) * 2017-12-06 2021-02-26 广州恒宁生物科技有限公司 一种促进皮肤损伤修复的小分子多肽及其应用
CN108715600B (zh) * 2018-04-12 2021-07-13 中国科学院南海海洋研究所 一种促进肠黏膜上皮细胞增殖和迁移的寡肽及其制备方法和应用
CN110903348B (zh) * 2019-12-10 2022-04-29 南京财经大学 一种促进伤口愈合的小肽及其应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117045534A (zh) * 2023-10-12 2023-11-14 深圳市维琪科技股份有限公司 六肽的新用途
CN117045534B (zh) * 2023-10-12 2024-01-23 深圳市维琪科技股份有限公司 六肽的新用途

Also Published As

Publication number Publication date
WO2022002186A1 (zh) 2022-01-06
TW202202515A (zh) 2022-01-16
IL299498A (en) 2023-02-01
JP2023531282A (ja) 2023-07-21
AU2021302188A1 (en) 2023-02-02
EP4177259A1 (en) 2023-05-10
CN113880915B (zh) 2024-02-13
CA3184710A1 (en) 2022-01-06
CN113880915A (zh) 2022-01-04
KR20230031898A (ko) 2023-03-07
US20230295233A1 (en) 2023-09-21

Similar Documents

Publication Publication Date Title
CN113880915B (zh) 用于修复黏膜损伤或皮肤创伤的多肽及其应用
JPH07223967A (ja) 消化器疾患治療薬
KR20210016365A (ko) 새로운 약제학적 용도
CN113248628B (zh) 一种乳源多肽衍生物及其在制备肥胖症防治药物、保健品和食品添加物中的应用
KR20180135444A (ko) 생물활성 풀베이트 분획의 조성물 및 이의 용도
JPH05503103A (ja) 障害を受けた組織における血管漏洩を抑制する抗炎症ペプチド及びその組織の治療方法
CN103641889B (zh) 一种降糖肽及其药物用途
WO2022148289A1 (zh) 一类用于修复皮肤损伤或黏膜损伤的多肽及其应用
KR20210114962A (ko) 류코트리엔 수용체 길항제를 함유하는 신규 제제
JPS60231618A (ja) 胃腸潰瘍の治癒促進用製剤組成物
CN114106100B (zh) 用于修复皮肤创伤或黏膜损伤的多肽及其应用
CN110372800B (zh) 具有多功能活性的融合多肽及其应用
US9364510B2 (en) Botanical composition and methods of manufacture and use
CN114773428A (zh) 新多肽及其在制备治疗皮肤创面或黏膜损伤药物中的应用
CN110772632A (zh) 神经导向因子semaphorin 3a在制备治疗骨关节炎药物中的用途
TW202330573A (zh) 一種多肽在製備用於預防或治療皮膚損傷疾病產品中之應用
CN116003529A (zh) 多肽及其在修复黏膜损伤或皮肤损伤上的应用
WO2023138644A1 (zh) 多肽化合物及其治疗肠炎的用途
CN115944711A (zh) 四肽在制备用于黏膜损伤或皮肤损伤修复的药物中的应用
CN108853483B (zh) 经修饰的胸腺素β4在治疗脑缺血再灌注损伤方面的用途
CN118119398A (zh) 一种多肽在制备用于预防或治疗皮肤损伤疾病产品上的应用
CN103012555A (zh) 具有组织保护活性的新多肽的制备方法及在治疗中的应用
EP4289860A1 (en) Use of polypeptide compound in prevention or treatment of inflammatory bowel disease and intestinal fibrosis related thereto
CN115944709A (zh) 一种三肽在制备用于黏膜或皮肤损伤修复的药物中的应用
CN115944708A (zh) 三肽在制备治疗和/或预防黏膜或皮肤损伤药物中的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40085790

Country of ref document: HK